Financhill
Back

Zai Lab Quote, Financials, Valuation and Earnings

Zai Lab Price Quote

$26.75
+0.01 (+2.02%)
(Updated: December 21, 2024 at 5:55 AM ET)

Zai Lab Key Stats

Sell
48
Zai Lab (ZLAB) is a Sell

Day range:
$25.96 - $27.33
52-week range:
$13.48 - $36.60
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
7.33
P/B ratio:
4.3%

Volume:
392.1K
Avg. volume:
1.1M
1-year change:
-7.28%
Market cap:
$2.9B
Revenue:
$266.7M
EPS:
$-2.7

How Much Does Zai Lab Make?

Data Unavailable

Is Zai Lab Growing As A Company?

Data Unavailable

Zai Lab Stock Price Performance

  • Did Zai Lab Stock Go Up Last Month?
    Zai Lab share price went up by 1.94% last month
  • Did ZLAB's Share Price Rise Over The Last Year?
    ZLAB share price fell by -7.28% over the past 1 year

What Is Zai Lab 52-Week High & Low?

  • What Is Zai Lab’s 52-Week High Share Price?
    Zai Lab has traded as high as $36.60 over the past 52 weeks
  • What Is Zai Lab’s 52-Week Low Share Price?
    Zai Lab has traded as low as $13.48 over the past 52 weeks

Zai Lab Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Zai Lab?

Data Unavailable

Is Zai Lab Cash Flow Positive?

Data Unavailable

Zai Lab Return On Invested Capital

Data Unavailable

Zai Lab Earnings Date & Stock Price

  • What Is Zai Lab's Stock Price Today?
    A single share of ZLAB can be purchased today for 26.74
  • What Is Zai Lab’s Stock Symbol?
    Zai Lab trades on the nasdaq under the ticker symbol: ZLAB
  • When Is Zai Lab’s Next Earnings Date?
    The next quarterly earnings date for Zai Lab is scheduled on February 27, 2025
  • When Is ZLAB's next ex-dividend date?
    Zai Lab's next ex-dividend date is June 20, 2020
  • How To Buy Zai Lab Stock?
    You can buy Zai Lab shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Zai Lab Competitors

  • Who Are Zai Lab's Competitors?
    Below is a list of companies who compete with Zai Lab or are related in some way:
    • Concord Medical Services Holdings Ltd (CCM)
    • NovoCure Ltd (NVCR)
    • Dr Reddy's Laboratories Ltd (RDY)
    • WuXi Biologics (Cayman) Inc (WXXWY)
    • 111 Inc (YI)

Zai Lab Dividend Yield

Data Unavailable

Zai Lab Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 46.34%
Revenue: 47.72% 0.02%

Analyst Recommendations

Buy Recommendations: 8
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 52.39
Upside from Last Price: 95.93%

Major Shareholders

Data Unavailable